Compare Invesco Solar ETF (TAN) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Solar ETF vs Zoetis Inc — how do they compare? Invesco Solar ETF trades at $47.65, while Zoetis Inc trades at $73.83 (market cap $30.29B). The key difference: Zoetis Inc pays a 2.89% dividend while Invesco Solar ETF pays none, and Invesco Solar ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.
| TAN | ZTS | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $73.95 | $150.61 |
52-Week Low | $41.78 | $71.91 |
Market Cap | — | $30.29B |
Enterprise Value | — | $37.86B |
Dividend Yield | — | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TAN trades at $49.13, up 2.27% today, but technical signals are bearish with moving averages indicating selling pressure. The ETF faces mixed sentiment, with recent news highlighting both policy tailwinds from U.S. polysilicon tariffs and headwinds from market saturation concerns. Financial ratios are unavailable, but the fund's high expense ratio of 0.7% and volatility remain notable.
Outlook is cautious; while geopolitical shifts and AI-driven power demand support long-term solar growth, near-term risks include price deflation, regulatory delays, and underperformance versus broader markets. Investors should weigh sector potential against persistent volatility and cost inefficiencies.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
